NDRG1 and breast carcinoma: Dp44mT exhibits anticancer activity in a number of cancers, such as leukemia, neuroblastoma, oral, lung, prostate and breast cancer, by promoting apoptosis, inducing cell cycle arrest and upregulating the expression of NDRG1 [27].